BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tian X, Dai S, Sun J, Jiang S, Jiang Y. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies. Oncotarget 2017;8:1156-65. [PMID: 27901479 DOI: 10.18632/oncotarget.13589] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yan H, Jiang F, Yang J, Xu Y. Association of β-Catenin, APC, SMAD3/4, Tp53, and Cyclin D1 Genes in Colorectal Cancer: A Systematic Review and Meta-Analysis. Genetics Research 2022;2022:1-21. [DOI: 10.1155/2022/5338956] [Reference Citation Analysis]
2 Mondal MSA, Kabir Y. Host Immune Gene Polymorphism and Cancer. Handbook of Cancer and Immunology 2022. [DOI: 10.1007/978-3-030-80962-1_48-1] [Reference Citation Analysis]
3 Banday MZ, Sameer AS, Nissar S. Colorectal Cancer and Genetic Polymorphism in Key Regulatory Low Penetrance Genes. Genetic Polymorphism and cancer susceptibility 2021. [DOI: 10.1007/978-981-33-6699-2_5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Drokow EK, Chen Y, Waqas Ahmed HA, Oppong TB, Akpabla GS, Pei Y, Kumah MA, Neku EA, Sun K. The relationship between leukemia and TP53 gene codon Arg72Pro polymorphism: analysis in a multi-ethnic population. Future Oncol 2020;16:923-37. [PMID: 32301350 DOI: 10.2217/fon-2019-0792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Elshazli RM, Toraih EA, Elgaml A, Kandil E, Fawzy MS. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies. Gene 2020;734:144391. [PMID: 32001373 DOI: 10.1016/j.gene.2020.144391] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
6 Yang J, Wu X, Huang J, Chen Z, Huang G, Guo X, Zhu L, Su L. TP53 Polymorphism Contributes to the Susceptibility to Bipolar Disorder but Not to Schizophrenia in the Chinese Han Population. J Mol Neurosci 2019;68:679-87. [DOI: 10.1007/s12031-019-01330-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhang G, Xu Q, Liu J, Lv Z, Lu Y, Yang H, Sun L, Xing C, Yuan Y. Five P53 SNPs Involved in Low Rectal Cancer Risk and Prognosis in a Chinese Population. J Cancer 2019;10:1772-80. [PMID: 31205533 DOI: 10.7150/jca.26722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Pouladi N, Abdolahi S, Farajzadeh D, Feizi MAHP. Association of the 17p13.1 region gene variants rs1042522 and rs2287499 with risk of breast cancer in Iranian-Azeri population. Meta Gene 2019;19:117-22. [DOI: 10.1016/j.mgene.2018.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
9 Li J, Liu X, Qiao Y, Qi R, Liu S, Guo J, Gui Y, Li J, Yu H. Association Between Genetic Variant in the Promoter of Pri-miR-34b/c and Risk of Glioma. Front Oncol 2018;8:413. [PMID: 30319976 DOI: 10.3389/fonc.2018.00413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sun Z, Gao W, Cui JT. Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis. BMC Oral Health 2018;18:143. [PMID: 30126398 DOI: 10.1186/s12903-018-0603-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Dong Z, Zheng L, Liu W, Wang C. Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis. Cancer Manag Res 2018;10:1341-9. [PMID: 29872345 DOI: 10.2147/CMAR.S164892] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Vodicka P, Musak L, Vodickova L, Vodenkova S, Catalano C, Kroupa M, Naccarati A, Polivkova Z, Vymetalkova V, Försti A, Hemminki K. Genetic variation of acquired structural chromosomal aberrations. Mutat Res Genet Toxicol Environ Mutagen 2018;836:13-21. [PMID: 30389156 DOI: 10.1016/j.mrgentox.2018.05.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
13 Das R, Kundu S, Laskar S, Choudhury Y, Ghosh SK. Assessment of DNA repair susceptibility genes identified by whole exome sequencing in head and neck cancer. DNA Repair (Amst). 2018;66-67:50-63. [PMID: 29747023 DOI: 10.1016/j.dnarep.2018.04.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
14 Schulz E, Sill H. The TP53 Pro72Arg SNP in de novo acute myeloid leukemia. Haematologica 2017;102:e214-5. [PMID: 28458254 DOI: 10.3324/haematol.2017.165019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Elsaid A, Zahran R, Elshazli R, El-sayed A, Abou Samra M, El-tarapely F, Abdel-malak C. Genetic polymorphisms of TP53 Arg72Pro and Pro47Ser among Egyptian patients with colorectal carcinoma. Archives of Physiology and Biochemistry 2018;125:255-62. [DOI: 10.1080/13813455.2018.1453522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Tan SC. Low penetrance genetic polymorphisms as potential biomarkers for colorectal cancer predisposition. J Gene Med 2018;20:e3010. [PMID: 29424105 DOI: 10.1002/jgm.3010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
17 Alamri AM, Liu X, Blancato JK, Haddad BR, Wang W, Zhong X, Choudhary S, Krawczyk E, Kallakury BV, Davidson BJ, Furth PA. Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing. Dis Model Mech 2018;11:dmm031716. [PMID: 29419396 DOI: 10.1242/dmm.031716] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
18 Liu Y, Wang X, Ding N, Mi L, Ping L, Jin X, Li J, Xie Y, Ying Z, Liu W, Zhang C, Deng L, Song Y, Zhu J. TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP. BMC Cancer 2017;17:743. [PMID: 29126407 DOI: 10.1186/s12885-017-3760-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]